Orchid Cellmark Praises FBI Re-Evaluation of Requirements for Outsourcing DNA Forensic Testing to Private Laboratories

PRINCETON, N.J., April 12, 2010 (GLOBE NEWSWIRE) -- Orchid Cellmark Inc. (Nasdaq:ORCH), a leading international provider of identity DNA testing services, today praised the Federal Bureau of Investigation’s (FBI) announcement that it will re-evaluate the requirements for outsourcing forensic DNA testing to private laboratories.

MORE ON THIS TOPIC